Since cytoplasmic TR beta was discovered to stimulate PI3K and mTOR signaling, two pathways highly relevant for tumor cell growth and survival, this ‘non-genomic’ activity of cytoplasmic TR beta might also explain why (cytoplasmic) TR beta was linked to ovarian cancer aggressiveness in our analysis [18,24]. This evidence concerns the gene TXNRD2 and ovarian cancer.